U.S. stocks rose on Tuesday, bolstered by positive developments in U.S.-China trade negotiations. Commerce Secretary Howard Lutnick's comments that talks were progressing “really, really well” fueled investor optimism. The S&P 500 increased by 0.5%, achieving a three-day winning streak. Meanwhile, the Dow Jones Industrial Average gained 105 points, and the Nasdaq Composite advanced 0.6%. Discussions in London extended into a second day, with negotiators diligently working into the evening to finalize technical details, heightening expectations of an agreement that could prevent further tariff escalation. The energy sector led the gains, followed by consumer discretionary and healthcare, although industrials did not perform as strongly. Technology stocks were particularly robust, highlighted by Tesla's 5.7% surge, making it a leader among large-cap gainers. Conversely, JM Smucker dropped by 15.6%, citing margin pressures in its coffee segment due to tariffs. Elsewhere, Moderna declined by 1.7%, whereas Pfizer saw a 3% uptick following U.S. Health Secretary Robert Kennedy Jr.'s decision to remove all CDC vaccine policy advisors late Monday.